These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29520366)

  • 1. Microglial activation, white matter tract damage, and disability in MS.
    Rissanen E; Tuisku J; Vahlberg T; Sucksdorff M; Paavilainen T; Parkkola R; Rokka J; Gerhard A; Hinz R; Talbot PS; Rinne JO; Airas L
    Neurol Neuroimmunol Neuroinflamm; 2018 May; 5(3):e443. PubMed ID: 29520366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
    Bezukladova S; Tuisku J; Matilainen M; Vuorimaa A; Nylund M; Smith S; Sucksdorff M; Mohammadian M; Saunavaara V; Laaksonen S; Rokka J; Rinne JO; Rissanen E; Airas L
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations.
    Ciccarelli O; Werring DJ; Wheeler-Kingshott CA; Barker GJ; Parker GJ; Thompson AJ; Miller DH
    Neurology; 2001 Apr; 56(7):926-33. PubMed ID: 11294931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
    Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L
    J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion tensor magnetic resonance imaging in multiple sclerosis.
    Filippi M; Cercignani M; Inglese M; Horsfield MA; Comi G
    Neurology; 2001 Feb; 56(3):304-11. PubMed ID: 11171893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
    Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
    Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
    Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal damage in the optic radiation assessed by white matter tract integrity metrics is associated with retinal thinning in multiple sclerosis.
    Ngamsombat C; Tian Q; Fan Q; Russo A; Machado N; Polackal M; George IC; Witzel T; Klawiter EC; Huang SY
    Neuroimage Clin; 2020; 27():102293. PubMed ID: 32563921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
    Filippi M; Preziosa P; Pagani E; Copetti M; Mesaros S; Colombo B; Horsfield MA; Falini A; Comi G; Lassmann H; Rocca MA
    Mult Scler; 2013 Apr; 19(4):418-26. PubMed ID: 22907944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
    de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M
    J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI.
    Cercignani M; Bozzali M; Iannucci G; Comi G; Filippi M
    J Neurol; 2002 Jul; 249(7):875-83. PubMed ID: 12140672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imaging.
    Margoni M; Villani U; Silvestri E; Franciotta S; Anglani MG; Causin F; Rinaldi F; Perini P; Bertoldo A; Gallo P
    Mult Scler Relat Disord; 2022 Feb; 58():103396. PubMed ID: 35216779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natalizumab treatment reduces microglial activation in the white matter of the MS brain.
    Sucksdorff M; Tuisku J; Matilainen M; Vuorimaa A; Smith S; Keitilä J; Rokka J; Parkkola R; Nylund M; Rinne J; Rissanen E; Airas L
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e574. PubMed ID: 31355310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis.
    Griffin CM; Chard DT; Ciccarelli O; Kapoor B; Barker GJ; Thompson AI; Miller DH
    Mult Scler; 2001 Oct; 7(5):290-7. PubMed ID: 11724444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.
    Zivadinov R; Hagemeier J; Bergsland N; Tavazzi E; Weinstock-Guttman B
    Eur J Neurol; 2018 Mar; 25(3):584-e36. PubMed ID: 29316038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study.
    Kolasa M; Hakulinen U; Brander A; Hagman S; Dastidar P; Elovaara I; Sumelahti ML
    Brain Behav; 2019 Jan; 9(1):e01194. PubMed ID: 30588771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.
    Moll NM; Rietsch AM; Thomas S; Ransohoff AJ; Lee JC; Fox R; Chang A; Ransohoff RM; Fisher E
    Ann Neurol; 2011 Nov; 70(5):764-73. PubMed ID: 22162059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.